Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nkarta
Biotech
Why Nkarta's CEO wore head-to-toe pink at JPM—and why it matters
2025 was a year marked by profound uncertainty, driven in part by a federal crackdown on diversity, equity and inclusion measures.
Gabrielle Masson
Jan 20, 2026 4:25pm
JPM26: All of the meetings, none of the megadeals
Jan 15, 2026 4:30am
'Let that one go': Nkarta CEO urges US gov to drop China regs
Oct 16, 2025 2:00pm
Biotech leaders urge FDA to not restrict abortion pill access
Jul 2, 2025 2:14pm
Sanofi vaccine vet vaults to GSK—Chutes & Ladders
Jun 13, 2025 8:30am
Yet another exec departs CRISPR Tx—Chutes & Ladders
Mar 28, 2025 8:30am